Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis

Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka, Takeo Sakurai, Kazuyoshi Saito, Hideo Ohtsubo, Sang Joon Lee, Yoshihiro Nambu

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences